Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide (Q40691464)

22 September 2017

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

1 reference

Donadio JV Jr

1

1 reference

22 September 2017

J. V. Donadio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

K. E. Holley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

R. H. Ferguson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

D. M. Ilstrup

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

language of work or name

English

0 references

publication date

1 November 1978

1 reference

22 September 2017

23 November 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=309095

full work available at URL

7 March 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197811232992102

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The New England Journal of Medicine

7 March 2023

published in

1 reference

22 September 2017

299

1 reference

22 September 2017

1151-1155

1 reference

22 September 2017

21

1 reference

Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine

22 September 2017

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months

7 March 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

4

51

484

Donadio

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The Effect of Treatment with Prednisone and Nitrogen Mustard on the Renal Lesions and Life Span of Patients with Lupus Glomerulonephritis

7 March 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Criteria for the classification of systemic lupus erythematosus--status 1972.

7 March 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

7

50

121

Velosa

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Detection of circulating immune complexes in patients with glomerulonephritis

7 March 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

7 March 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

7 March 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential

7 March 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The bimodal mortality pattern of systemic lupus erythematosus

7 March 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

7 March 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

Identifiers

1 reference

22 September 2017

1 reference